Intellia Therapeutics, Inc.
NTLA- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0001652130
In the last 90 days, Intellia Therapeutics, Inc. insiders filed 0 open-market purchases and 4 sales; 329 institutions reported holding it in 13F filings for Q2 2026, worth $2.43B in total; ARK Invest is the only superinvestor holding it.
13F holders, Q4 2021
Institutional positions in Intellia Therapeutics, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 372
- +10 vs. Q3 2021
- Shares held
- 64.2M
- +2.02M (+3.2%) vs. Q3 2021
- Total value
- $7.60B
- −$747.6M (−9.0%) vs. Q3 2021
- New holders
- 66
- 126 more added
- Sold out
- 56
- 118 more reduced
4 institutions that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting NTLA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 329 | $2.43B |
| Q1 2026 | 306 | $1.41B |
| Q4 2025 | 295 | $938.9M |
| Q3 2025 | 284 | $1.80B |
| Q2 2025 | 283 | $933.8M |
| Q1 2025 | 296 | $720.3M |
| Q4 2024 | 295 | $1.16B |
| Q3 2024 | 284 | $1.92B |
| Q2 2024 | 291 | $2.02B |
| Q1 2024 | 284 | $2.51B |
| Q4 2023 | 293 | $2.60B |
| Q3 2023 | 286 | $2.53B |
| Q2 2023 | 292 | $3.19B |
| Q1 2023 | 291 | $2.93B |
| Q4 2022 | 304 | $2.72B |
| Q3 2022 | 321 | $3.81B |
| Q2 2022 | 301 | $3.44B |
| Q1 2022 | 348 | $4.71B |
| Q4 2021 | 372 | $7.60B |
| Q3 2021 | 366 | $8.34B |
| Q2 2021 | 337 | $10.0B |
| Q1 2021 | 261 | $5.07B |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Intellia Therapeutics, Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| ExodusPoint Capital Management, LP | 0 | $0 | 0.00% | −3,467−100.0% | Sold out |
| Quantbot Technologies LP | 0 | $0 | 0.00% | −3,380−100.0% | Sold out |
| Cetera Advisors LLC | 0 | $0 | 0.00% | −3,321−100.0% | Sold out |
| Advisory Research Inc | 0 | $0 | 0.00% | −3,053−100.0% | Sold out |
| Treasurer of the State of North Carolina | 0 | $0 | 0.00% | −3,010−100.0% | Sold out |
| Brinker Capital Investments, LLC | 0 | $0 | 0.00% | −2,372−100.0% | Sold out |
| Quilter Plc | 0 | $0 | 0.00% | −2,350−100.0% | Sold out |
| Echo Street Capital Management LLC | 0 | $0 | 0.00% | −2,311−100.0% | Sold out |
| 1623 Capital LLC | 0 | $0 | 0.00% | −2,300−100.0% | Sold out |
| Capital Advisory Group Advisory Services, LLC | 0 | $0 | 0.00% | −2,233−100.0% | Sold out |
| Scholtz & Company, LLC | 0 | $0 | 0.00% | −2,185−100.0% | Sold out |
| Parametrica Management Ltd | 0 | $0 | 0.00% | −2,036−100.0% | Sold out |
| Meeder Asset Management Inc | 0 | $0 | 0.00% | −1,931−100.0% | Sold out |
| Oppenheimer & Co Inc | 0 | $0 | 0.00% | −1,824−100.0% | Sold out |
| Creative Planning | 0 | $0 | 0.00% | −1,810−100.0% | Sold out |
| Penserra Capital Management LLC | 0 | $0 | 0.00% | −1,680−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −1,652−100.0% | Sold out |
| Vident Investment Advisory, LLC | 0 | $0 | 0.00% | −1,628−100.0% | Sold out |
| CAPROCK Group, Inc. | 0 | $0 | 0.00% | −1,514−100.0% | Sold out |
| Point72 Hong Kong Ltd | 0 | $0 | 0.00% | −866−100.0% | Sold out |
| Herold Advisors, Inc. | 0 | $0 | 0.00% | −850−100.0% | Sold out |
| Venturi Wealth Management, LLC | 0 | $0 | 0.00% | −175−100.0% | Sold out |
| Pacitti Group Inc. | 0 | $0 | 0.00% | −80−100.0% | Sold out |
| Parallax Volatility Advisers, L.P. | 0 | $0 | 0.00% | −22−100.0% | Sold out |
| Meridian Wealth Partners, LLC | 0 | $0 | 0.00% | −25−100.0% | Sold out |
| Evolution Wealth Advisors, LLC | 0 | $0 | 0.00% | −17−100.0% | Sold out |
| TD Private Client Wealth LLC | 0 | $0 | 0.00% | −9−100.0% | Sold out |
| Berkshire Capital Holdings Inc | 0 | $0 | 0.00% | −10−100.0% | Sold out |
| Homrich & Berg | – | – | – | – | Not filed |
| Alexandria Capital, LLC | – | – | – | – | Not filed |
| First Mercantile Trust Co | – | – | – | – | Not filed |
| Berman Capital Advisors, LLC | – | – | – | – | Not filed |